Walgreen upgraded to Buy from Neutral at UBS

theflyonthewall.com

UBS upgraded Walgreen due to the recent sell-off in shares and positive developments longer term that include leverage to healthcare reform, stronger gross margins, and increased visibility regarding the Alliance Boots transaction. Price target raised to $48 from $41.

View Comments (0)